Figure S1
Expression Level Condition:
Mean expression of at least 15 reads in 2 of 12 ssue/treatment cond ons.
Result: 15510 genes
AhR at 37°C in humidified 5% CO 2 /95% air for 16h. Individual skin biopsies from healthy donors were processed in the same ways as those of patients.
Animals: Mice were bred in the NIMR animal facility under specified pathogen free conditions. All animal experiments were done according to institutional guidelines and Home
Office regulations. C57Bl/6, B6.CD45.1, Ahr -/- (Schmidt et al., 1996) Generation of BM chimeras: BM cells were obtained from femurs and tibias of donor mice.
Sub-lethally irradiated Rag1 deficient recipient mice were reconstituted by intravenous injection of 1x10 7 BM cells. Ensembl Human GRCh37 transcriptome using bowtie with the options "-v 3 -a --best -y -I 0 -X 10000". Any read pair mapping only to one or more transcripts of a gene constituted a unique gene count, and any read pair mapping to transcripts of different genes was discarded.
RNA isolation and
On average 60.5% of reads produced unique mappings. Read counts were normalised by the total unique mapping reads per library.
RNA sequencing differential expression analysis
We tested for the influence of AhR agonist and antagonist whilst controlling for any tissue culture effect. We first estimate the perturbation due to culture (if any), then we estimate the fold change and significance of the AhR treatment beyond that of the culture. Let be the normalised count of gene in tissue under treatment = {U = Untreated, C = DMSO, T=AhR Agonist/Antagonist} in patient , we assume is negative binomially distributed (Cameron and Trived, 1998) with mean and variance , with the dispersion parameter for gene in tissue . We consider the null hypothesis a gene's expression is the result of the mean untreated expression and any culture effects: ; and the alternative hypothesis that a gene's expression is due to mean untreated expression, culture and treatment effects:
. Where, is the mean untreated expression; and are the log fold changes due to culture and treatment respectively; when and 0 otherwise; when and 0 otherwise. We compute maximum likelihood estimates of parameters under the null, and similarly estimates of under the alternative hypothesis. We perform a likelihood ratio test: if and are the log-likelihoods of the null and alternative models respectively then the test statistic is assumed distributed under the null hypothesis. We apply the test to the 15510 genes that have a mean expression of at least 15 reads in 2 of the 12 tissue/treatment combinations. We select the genes for which we reject the null with in any treatment and tissue, we further require the treatment fold changes must be opposing in the relevant tissue (i.e. must have different signs for agonist and antagonist). This results in 884 AhR-modulated genes (Fig. 1A) . We next filtered for consistency of treatment by requiring one of the two treatments to be significant in both lesional (L) and non-lesional(NL), and that the treatment fold changes must be opposing in one of these two tissues. This results in 51 genes of which we select the 41 most likely to be disease relevant by retaining those differentially expressed in an Untreated L v NL comparison with determined by DESeq (Anders and Huber, 2010) .
Microarray gene expression analysis (Accession number GSE47607)
Total RNA was used for the Affymetrix sample preparations (Affymetrix) according to the manufacturer's instructions. Three biological repeats were hybridized to GeneChip Mouse Genome 430 2.0 Arrays. Microarray data were RMA normalized using the R package affy (Bolstad et al., 2003) that is a part of the Bioconductor project (http://www.bioconductor.org). Fold changes were calculated as 2|SLR| if SLR>0 and -2|SLR| if SLR<0, where SLR is the average signal log ratio over the biological replicates.
The R package RankProd (Hong et al., 2006 ) was used to identify regulated genes. Genes having the estimated percentage of false positive predictions pfp<0.01 and fold change FC≥1.5 were considered to be differentially expressed. The gene annotations were obtained from the NetAffx database (Liu et al., 2003) . Visualization was performed using Eisen's
